nodes	percent_of_prediction	percent_of_DWPC	metapath
Levetiracetam—ABCB1—melanoma	0.507	1	CbGaD
Levetiracetam—ABCC2—Docetaxel—melanoma	0.095	0.511	CbGbCtD
Levetiracetam—ABCB1—Dactinomycin—melanoma	0.06	0.323	CbGbCtD
Levetiracetam—ABCB1—Docetaxel—melanoma	0.031	0.167	CbGbCtD
Levetiracetam—SV2A—Uptake and actions of bacterial toxins—MAP2K2—melanoma	0.00336	0.073	CbGpPWpGaD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCB5—melanoma	0.0027	0.0587	CbGpPWpGaD
Levetiracetam—SV2A—Uptake and actions of bacterial toxins—MAP2K1—melanoma	0.00238	0.0517	CbGpPWpGaD
Levetiracetam—ABCC2—Codeine and Morphine Metabolism—ABCB1—melanoma	0.00144	0.0313	CbGpPWpGaD
Levetiracetam—ABCB1—ABC-family proteins mediated transport—ABCB5—melanoma	0.00127	0.0276	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—SLC6A11—melanoma	0.00117	0.0255	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—SLC6A11—melanoma	0.000898	0.0195	CbGpPWpGaD
Levetiracetam—Stomatitis—Bleomycin—melanoma	0.000885	0.00338	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—SLC39A12—melanoma	0.000881	0.0192	CbGpPWpGaD
Levetiracetam—Muscular weakness—Temozolomide—melanoma	0.000876	0.00335	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000871	0.00333	CcSEcCtD
Levetiracetam—Pancytopenia—Carmustine—melanoma	0.000844	0.00323	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000839	0.00321	CcSEcCtD
Levetiracetam—Neutropenia—Carmustine—melanoma	0.000831	0.00318	CcSEcCtD
Levetiracetam—Decreased appetite—Vemurafenib—melanoma	0.000831	0.00318	CcSEcCtD
Levetiracetam—Bronchitis—Temozolomide—melanoma	0.000826	0.00316	CcSEcCtD
Levetiracetam—Stomatitis—Dactinomycin—melanoma	0.000825	0.00316	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Vemurafenib—melanoma	0.000825	0.00316	CcSEcCtD
Levetiracetam—Fatigue—Vemurafenib—melanoma	0.000824	0.00315	CcSEcCtD
Levetiracetam—Constipation—Vemurafenib—melanoma	0.000817	0.00313	CcSEcCtD
Levetiracetam—Pancytopenia—Temozolomide—melanoma	0.000815	0.00312	CcSEcCtD
Levetiracetam—Neutropenia—Temozolomide—melanoma	0.000803	0.00307	CcSEcCtD
Levetiracetam—Upper respiratory tract infection—Temozolomide—melanoma	0.000798	0.00305	CcSEcCtD
Levetiracetam—Depression—Carmustine—melanoma	0.00079	0.00302	CcSEcCtD
Levetiracetam—Agranulocytosis—Dactinomycin—melanoma	0.00079	0.00302	CcSEcCtD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—melanoma	0.000788	0.0171	CbGpPWpGaD
Levetiracetam—ABCC2—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.000786	0.0171	CbGpPWpGaD
Levetiracetam—Weight increased—Temozolomide—melanoma	0.000781	0.00299	CcSEcCtD
Levetiracetam—Weight decreased—Temozolomide—melanoma	0.000777	0.00297	CcSEcCtD
Levetiracetam—Stomatitis—Carmustine—melanoma	0.000772	0.00295	CcSEcCtD
Levetiracetam—Urinary tract infection—Carmustine—melanoma	0.00077	0.00295	CcSEcCtD
Levetiracetam—Infestation—Temozolomide—melanoma	0.000766	0.00293	CcSEcCtD
Levetiracetam—Infestation NOS—Temozolomide—melanoma	0.000766	0.00293	CcSEcCtD
Levetiracetam—Depression—Temozolomide—melanoma	0.000763	0.00292	CcSEcCtD
Levetiracetam—Hepatitis—Dactinomycin—melanoma	0.00076	0.00291	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000759	0.0029	CcSEcCtD
Levetiracetam—Body temperature increased—Vemurafenib—melanoma	0.000755	0.00289	CcSEcCtD
Levetiracetam—Pharyngitis—Dactinomycin—melanoma	0.000754	0.00288	CcSEcCtD
Levetiracetam—Stomatitis—Temozolomide—melanoma	0.000746	0.00285	CcSEcCtD
Levetiracetam—Urinary tract infection—Temozolomide—melanoma	0.000744	0.00285	CcSEcCtD
Levetiracetam—Hepatic failure—Docetaxel—melanoma	0.000735	0.00281	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Temozolomide—melanoma	0.000724	0.00277	CcSEcCtD
Levetiracetam—SV2A—Disease—MYO7A—melanoma	0.000721	0.0157	CbGpPWpGaD
Levetiracetam—Alopecia—Bleomycin—melanoma	0.00072	0.00275	CcSEcCtD
Levetiracetam—Erythema multiforme—Dactinomycin—melanoma	0.000719	0.00275	CcSEcCtD
Levetiracetam—Sinusitis—Temozolomide—melanoma	0.000718	0.00275	CcSEcCtD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—GRIN2A—melanoma	0.000716	0.0156	CbGpPWpGaD
Levetiracetam—Hallucination—Carmustine—melanoma	0.000708	0.00271	CcSEcCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—GNA11—melanoma	0.000704	0.0153	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Vemurafenib—melanoma	0.000704	0.00269	CcSEcCtD
Levetiracetam—Connective tissue disorder—Carmustine—melanoma	0.000699	0.00267	CcSEcCtD
Levetiracetam—Renal impairment—Docetaxel—melanoma	0.000694	0.00266	CcSEcCtD
Levetiracetam—Dermatitis bullous—Docetaxel—melanoma	0.000691	0.00264	CcSEcCtD
Levetiracetam—Hepatitis—Temozolomide—melanoma	0.000687	0.00263	CcSEcCtD
Levetiracetam—Asthenia—Vemurafenib—melanoma	0.000686	0.00262	CcSEcCtD
Levetiracetam—Hallucination—Temozolomide—melanoma	0.000684	0.00262	CcSEcCtD
Levetiracetam—Pharyngitis—Temozolomide—melanoma	0.000682	0.00261	CcSEcCtD
Levetiracetam—Pruritus—Vemurafenib—melanoma	0.000676	0.00259	CcSEcCtD
Levetiracetam—Connective tissue disorder—Temozolomide—melanoma	0.000675	0.00258	CcSEcCtD
Levetiracetam—Lethargy—Docetaxel—melanoma	0.000674	0.00258	CcSEcCtD
Levetiracetam—Alopecia—Dactinomycin—melanoma	0.000672	0.00257	CcSEcCtD
Levetiracetam—Eye disorder—Carmustine—melanoma	0.000665	0.00254	CcSEcCtD
Levetiracetam—Hyponatraemia—Docetaxel—melanoma	0.000663	0.00254	CcSEcCtD
Levetiracetam—ABCC2—Irinotecan Pathway—APC—melanoma	0.000663	0.0144	CbGpPWpGaD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—GNAQ—melanoma	0.000655	0.0142	CbGpPWpGaD
Levetiracetam—Diarrhoea—Vemurafenib—melanoma	0.000654	0.0025	CcSEcCtD
Levetiracetam—Erythema multiforme—Temozolomide—melanoma	0.00065	0.00249	CcSEcCtD
Levetiracetam—Eye disorder—Temozolomide—melanoma	0.000642	0.00246	CcSEcCtD
Levetiracetam—Leukopenia—Bleomycin—melanoma	0.000635	0.00243	CcSEcCtD
Levetiracetam—Dizziness—Vemurafenib—melanoma	0.000632	0.00242	CcSEcCtD
Levetiracetam—Alopecia—Carmustine—melanoma	0.000629	0.0024	CcSEcCtD
Levetiracetam—Mental disorder—Carmustine—melanoma	0.000623	0.00238	CcSEcCtD
Levetiracetam—Ataxia—Docetaxel—melanoma	0.000621	0.00238	CcSEcCtD
Levetiracetam—Immune system disorder—Temozolomide—melanoma	0.000621	0.00237	CcSEcCtD
Levetiracetam—Mediastinal disorder—Temozolomide—melanoma	0.000619	0.00237	CcSEcCtD
Levetiracetam—Malnutrition—Carmustine—melanoma	0.000619	0.00237	CcSEcCtD
Levetiracetam—Cough—Bleomycin—melanoma	0.000619	0.00237	CcSEcCtD
Levetiracetam—Dehydration—Docetaxel—melanoma	0.000614	0.00235	CcSEcCtD
Levetiracetam—SV2A—Disease—HS3ST5—melanoma	0.000613	0.0133	CbGpPWpGaD
Levetiracetam—Liver function test abnormal—Docetaxel—melanoma	0.00061	0.00233	CcSEcCtD
Levetiracetam—Vomiting—Vemurafenib—melanoma	0.000608	0.00232	CcSEcCtD
Levetiracetam—Alopecia—Temozolomide—melanoma	0.000607	0.00232	CcSEcCtD
Levetiracetam—Chest pain—Bleomycin—melanoma	0.000604	0.00231	CcSEcCtD
Levetiracetam—Myalgia—Bleomycin—melanoma	0.000604	0.00231	CcSEcCtD
Levetiracetam—Abdominal pain upper—Docetaxel—melanoma	0.000603	0.00231	CcSEcCtD
Levetiracetam—Rash—Vemurafenib—melanoma	0.000602	0.0023	CcSEcCtD
Levetiracetam—Mental disorder—Temozolomide—melanoma	0.000602	0.0023	CcSEcCtD
Levetiracetam—Dermatitis—Vemurafenib—melanoma	0.000602	0.0023	CcSEcCtD
Levetiracetam—Back pain—Carmustine—melanoma	0.000599	0.00229	CcSEcCtD
Levetiracetam—Headache—Vemurafenib—melanoma	0.000599	0.00229	CcSEcCtD
Levetiracetam—Malnutrition—Temozolomide—melanoma	0.000598	0.00229	CcSEcCtD
Levetiracetam—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000595	0.00228	CcSEcCtD
Levetiracetam—Leukopenia—Dactinomycin—melanoma	0.000592	0.00226	CcSEcCtD
Levetiracetam—Nasopharyngitis—Docetaxel—melanoma	0.000591	0.00226	CcSEcCtD
Levetiracetam—Confusional state—Bleomycin—melanoma	0.000584	0.00223	CcSEcCtD
Levetiracetam—Vision blurred—Carmustine—melanoma	0.000584	0.00223	CcSEcCtD
Levetiracetam—Tremor—Carmustine—melanoma	0.00058	0.00222	CcSEcCtD
Levetiracetam—Back pain—Temozolomide—melanoma	0.000579	0.00221	CcSEcCtD
Levetiracetam—Infection—Bleomycin—melanoma	0.000575	0.0022	CcSEcCtD
Levetiracetam—Agitation—Carmustine—melanoma	0.000569	0.00218	CcSEcCtD
Levetiracetam—Nausea—Vemurafenib—melanoma	0.000568	0.00217	CcSEcCtD
Levetiracetam—Thrombocytopenia—Bleomycin—melanoma	0.000567	0.00217	CcSEcCtD
Levetiracetam—Vision blurred—Temozolomide—melanoma	0.000564	0.00216	CcSEcCtD
Levetiracetam—Myalgia—Dactinomycin—melanoma	0.000563	0.00215	CcSEcCtD
Levetiracetam—Tremor—Temozolomide—melanoma	0.000561	0.00214	CcSEcCtD
Levetiracetam—Leukopenia—Carmustine—melanoma	0.000554	0.00212	CcSEcCtD
Levetiracetam—Anorexia—Bleomycin—melanoma	0.000552	0.00211	CcSEcCtD
Levetiracetam—Agitation—Temozolomide—melanoma	0.00055	0.0021	CcSEcCtD
Levetiracetam—CACNA1B—Neuronal System—GRIN2A—melanoma	0.000548	0.0119	CbGpPWpGaD
Levetiracetam—Pancytopenia—Docetaxel—melanoma	0.000542	0.00207	CcSEcCtD
Levetiracetam—Vertigo—Temozolomide—melanoma	0.000538	0.00206	CcSEcCtD
Levetiracetam—Convulsion—Carmustine—melanoma	0.000536	0.00205	CcSEcCtD
Levetiracetam—Infection—Dactinomycin—melanoma	0.000536	0.00205	CcSEcCtD
Levetiracetam—Leukopenia—Temozolomide—melanoma	0.000536	0.00205	CcSEcCtD
Levetiracetam—Neutropenia—Docetaxel—melanoma	0.000534	0.00204	CcSEcCtD
Levetiracetam—Thrombocytopenia—Dactinomycin—melanoma	0.000529	0.00202	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Bleomycin—melanoma	0.000527	0.00202	CcSEcCtD
Levetiracetam—Myalgia—Carmustine—melanoma	0.000527	0.00202	CcSEcCtD
Levetiracetam—Chest pain—Carmustine—melanoma	0.000527	0.00202	CcSEcCtD
Levetiracetam—Anxiety—Carmustine—melanoma	0.000525	0.00201	CcSEcCtD
Levetiracetam—Cough—Temozolomide—melanoma	0.000522	0.002	CcSEcCtD
Levetiracetam—Paraesthesia—Bleomycin—melanoma	0.00052	0.00199	CcSEcCtD
Levetiracetam—Weight increased—Docetaxel—melanoma	0.00052	0.00199	CcSEcCtD
Levetiracetam—Convulsion—Temozolomide—melanoma	0.000518	0.00198	CcSEcCtD
Levetiracetam—Weight decreased—Docetaxel—melanoma	0.000517	0.00198	CcSEcCtD
Levetiracetam—Anorexia—Dactinomycin—melanoma	0.000515	0.00197	CcSEcCtD
Levetiracetam—Confusional state—Carmustine—melanoma	0.00051	0.00195	CcSEcCtD
Levetiracetam—Arthralgia—Temozolomide—melanoma	0.000509	0.00195	CcSEcCtD
Levetiracetam—Myalgia—Temozolomide—melanoma	0.000509	0.00195	CcSEcCtD
Levetiracetam—Infestation—Docetaxel—melanoma	0.000509	0.00195	CcSEcCtD
Levetiracetam—Infestation NOS—Docetaxel—melanoma	0.000509	0.00195	CcSEcCtD
Levetiracetam—Anxiety—Temozolomide—melanoma	0.000508	0.00194	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000506	0.00193	CcSEcCtD
Levetiracetam—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000505	0.00193	CcSEcCtD
Levetiracetam—Decreased appetite—Bleomycin—melanoma	0.000503	0.00192	CcSEcCtD
Levetiracetam—Infection—Carmustine—melanoma	0.000502	0.00192	CcSEcCtD
Levetiracetam—Stomatitis—Docetaxel—melanoma	0.000496	0.0019	CcSEcCtD
Levetiracetam—Pain—Bleomycin—melanoma	0.000495	0.00189	CcSEcCtD
Levetiracetam—Conjunctivitis—Docetaxel—melanoma	0.000495	0.00189	CcSEcCtD
Levetiracetam—Thrombocytopenia—Carmustine—melanoma	0.000495	0.00189	CcSEcCtD
Levetiracetam—Confusional state—Temozolomide—melanoma	0.000492	0.00188	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000492	0.00188	CcSEcCtD
Levetiracetam—Infection—Temozolomide—melanoma	0.000485	0.00186	CcSEcCtD
Levetiracetam—Anorexia—Carmustine—melanoma	0.000482	0.00184	CcSEcCtD
Levetiracetam—Hepatobiliary disease—Docetaxel—melanoma	0.000482	0.00184	CcSEcCtD
Levetiracetam—Epistaxis—Docetaxel—melanoma	0.00048	0.00184	CcSEcCtD
Levetiracetam—Nervous system disorder—Temozolomide—melanoma	0.000479	0.00183	CcSEcCtD
Levetiracetam—Thrombocytopenia—Temozolomide—melanoma	0.000478	0.00183	CcSEcCtD
Levetiracetam—Feeling abnormal—Bleomycin—melanoma	0.000477	0.00182	CcSEcCtD
Levetiracetam—CACNA1B—Calcium Regulation in the Cardiac Cell—PRKCA—melanoma	0.000476	0.0103	CbGpPWpGaD
Levetiracetam—Agranulocytosis—Docetaxel—melanoma	0.000475	0.00182	CcSEcCtD
Levetiracetam—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—melanoma	0.000475	0.0103	CbGpPWpGaD
Levetiracetam—Skin disorder—Temozolomide—melanoma	0.000474	0.00181	CcSEcCtD
Levetiracetam—Decreased appetite—Dactinomycin—melanoma	0.000469	0.0018	CcSEcCtD
Levetiracetam—Fatigue—Dactinomycin—melanoma	0.000465	0.00178	CcSEcCtD
Levetiracetam—Anorexia—Temozolomide—melanoma	0.000465	0.00178	CcSEcCtD
Levetiracetam—Pain—Dactinomycin—melanoma	0.000462	0.00177	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Carmustine—melanoma	0.00046	0.00176	CcSEcCtD
Levetiracetam—Rhinitis—Docetaxel—melanoma	0.000458	0.00175	CcSEcCtD
Levetiracetam—Body temperature increased—Bleomycin—melanoma	0.000458	0.00175	CcSEcCtD
Levetiracetam—Hepatitis—Docetaxel—melanoma	0.000457	0.00175	CcSEcCtD
Levetiracetam—Insomnia—Carmustine—melanoma	0.000457	0.00175	CcSEcCtD
Levetiracetam—Paraesthesia—Carmustine—melanoma	0.000454	0.00174	CcSEcCtD
Levetiracetam—Pharyngitis—Docetaxel—melanoma	0.000454	0.00174	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—melanoma	0.000452	0.00984	CbGpPWpGaD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000452	0.00982	CbGpPWpGaD
Levetiracetam—Somnolence—Carmustine—melanoma	0.000449	0.00172	CcSEcCtD
Levetiracetam—Connective tissue disorder—Docetaxel—melanoma	0.000449	0.00172	CcSEcCtD
Levetiracetam—Feeling abnormal—Dactinomycin—melanoma	0.000445	0.0017	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Temozolomide—melanoma	0.000445	0.0017	CcSEcCtD
Levetiracetam—Insomnia—Temozolomide—melanoma	0.000442	0.00169	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Dactinomycin—melanoma	0.000441	0.00169	CcSEcCtD
Levetiracetam—Decreased appetite—Carmustine—melanoma	0.000439	0.00168	CcSEcCtD
Levetiracetam—Paraesthesia—Temozolomide—melanoma	0.000438	0.00168	CcSEcCtD
Levetiracetam—SV2A—Disease—TRRAP—melanoma	0.000437	0.0095	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CUL3—melanoma	0.000437	0.0095	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Carmustine—melanoma	0.000436	0.00167	CcSEcCtD
Levetiracetam—Somnolence—Temozolomide—melanoma	0.000434	0.00166	CcSEcCtD
Levetiracetam—ABCC2—ABC-family proteins mediated transport—ABCB1—melanoma	0.000432	0.0094	CbGpPWpGaD
Levetiracetam—Erythema multiforme—Docetaxel—melanoma	0.000432	0.00165	CcSEcCtD
Levetiracetam—Pain—Carmustine—melanoma	0.000432	0.00165	CcSEcCtD
Levetiracetam—Constipation—Carmustine—melanoma	0.000432	0.00165	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—EPHA2—melanoma	0.00043	0.00935	CbGpPWpGaD
Levetiracetam—Dyspepsia—Temozolomide—melanoma	0.00043	0.00164	CcSEcCtD
Levetiracetam—Eye disorder—Docetaxel—melanoma	0.000427	0.00163	CcSEcCtD
Levetiracetam—Body temperature increased—Dactinomycin—melanoma	0.000427	0.00163	CcSEcCtD
Levetiracetam—Abdominal pain—Dactinomycin—melanoma	0.000427	0.00163	CcSEcCtD
Levetiracetam—Hypersensitivity—Bleomycin—melanoma	0.000427	0.00163	CcSEcCtD
Levetiracetam—SV2A—Disease—AKR1B10—melanoma	0.000425	0.00924	CbGpPWpGaD
Levetiracetam—Decreased appetite—Temozolomide—melanoma	0.000424	0.00162	CcSEcCtD
Levetiracetam—Gastrointestinal disorder—Temozolomide—melanoma	0.000422	0.00161	CcSEcCtD
Levetiracetam—Fatigue—Temozolomide—melanoma	0.000421	0.00161	CcSEcCtD
Levetiracetam—Pain—Temozolomide—melanoma	0.000418	0.0016	CcSEcCtD
Levetiracetam—Constipation—Temozolomide—melanoma	0.000418	0.0016	CcSEcCtD
Levetiracetam—Feeling abnormal—Carmustine—melanoma	0.000416	0.00159	CcSEcCtD
Levetiracetam—Asthenia—Bleomycin—melanoma	0.000415	0.00159	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Carmustine—melanoma	0.000413	0.00158	CcSEcCtD
Levetiracetam—Immune system disorder—Docetaxel—melanoma	0.000413	0.00158	CcSEcCtD
Levetiracetam—Mediastinal disorder—Docetaxel—melanoma	0.000412	0.00158	CcSEcCtD
Levetiracetam—Pruritus—Bleomycin—melanoma	0.00041	0.00157	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—SLC6A11—melanoma	0.000404	0.00879	CbGpPWpGaD
Levetiracetam—Alopecia—Docetaxel—melanoma	0.000404	0.00154	CcSEcCtD
Levetiracetam—Feeling abnormal—Temozolomide—melanoma	0.000402	0.00154	CcSEcCtD
Levetiracetam—Mental disorder—Docetaxel—melanoma	0.0004	0.00153	CcSEcCtD
Levetiracetam—Abdominal pain—Carmustine—melanoma	0.000399	0.00153	CcSEcCtD
Levetiracetam—Body temperature increased—Carmustine—melanoma	0.000399	0.00153	CcSEcCtD
Levetiracetam—Gastrointestinal pain—Temozolomide—melanoma	0.000399	0.00153	CcSEcCtD
Levetiracetam—Malnutrition—Docetaxel—melanoma	0.000398	0.00152	CcSEcCtD
Levetiracetam—Hypersensitivity—Dactinomycin—melanoma	0.000398	0.00152	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ARNT—melanoma	0.000395	0.00859	CbGpPWpGaD
Levetiracetam—Asthenia—Dactinomycin—melanoma	0.000387	0.00148	CcSEcCtD
Levetiracetam—Abdominal pain—Temozolomide—melanoma	0.000386	0.00148	CcSEcCtD
Levetiracetam—Body temperature increased—Temozolomide—melanoma	0.000386	0.00148	CcSEcCtD
Levetiracetam—Back pain—Docetaxel—melanoma	0.000385	0.00147	CcSEcCtD
Levetiracetam—SV2A—Disease—LUM—melanoma	0.000379	0.00824	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—PRKCA—melanoma	0.000376	0.00817	CbGpPWpGaD
Levetiracetam—Hypersensitivity—Carmustine—melanoma	0.000372	0.00142	CcSEcCtD
Levetiracetam—SV2A—Disease—HPSE—melanoma	0.000371	0.00808	CbGpPWpGaD
Levetiracetam—ABCB1—Drug Induction of Bile Acid Pathway—VDR—melanoma	0.00037	0.00804	CbGpPWpGaD
Levetiracetam—Diarrhoea—Dactinomycin—melanoma	0.000369	0.00141	CcSEcCtD
Levetiracetam—Vomiting—Bleomycin—melanoma	0.000368	0.00141	CcSEcCtD
Levetiracetam—Rash—Bleomycin—melanoma	0.000365	0.0014	CcSEcCtD
Levetiracetam—Dermatitis—Bleomycin—melanoma	0.000365	0.00139	CcSEcCtD
Levetiracetam—SV2A—Disease—CUBN—melanoma	0.000365	0.00793	CbGpPWpGaD
Levetiracetam—Asthenia—Carmustine—melanoma	0.000363	0.00139	CcSEcCtD
Levetiracetam—Hypersensitivity—Temozolomide—melanoma	0.00036	0.00138	CcSEcCtD
Levetiracetam—Leukopenia—Docetaxel—melanoma	0.000356	0.00136	CcSEcCtD
Levetiracetam—SV2A—Disease—CSPG4—melanoma	0.000352	0.00766	CbGpPWpGaD
Levetiracetam—Asthenia—Temozolomide—melanoma	0.00035	0.00134	CcSEcCtD
Levetiracetam—Cough—Docetaxel—melanoma	0.000347	0.00133	CcSEcCtD
Levetiracetam—SV2A—Disease—RPS3—melanoma	0.000346	0.00753	CbGpPWpGaD
Levetiracetam—Diarrhoea—Carmustine—melanoma	0.000346	0.00132	CcSEcCtD
Levetiracetam—Pruritus—Temozolomide—melanoma	0.000345	0.00132	CcSEcCtD
Levetiracetam—Convulsion—Docetaxel—melanoma	0.000345	0.00132	CcSEcCtD
Levetiracetam—Nausea—Bleomycin—melanoma	0.000344	0.00132	CcSEcCtD
Levetiracetam—Vomiting—Dactinomycin—melanoma	0.000343	0.00131	CcSEcCtD
Levetiracetam—SV2A—Disease—SKI—melanoma	0.000341	0.00742	CbGpPWpGaD
Levetiracetam—Rash—Dactinomycin—melanoma	0.00034	0.0013	CcSEcCtD
Levetiracetam—Myalgia—Docetaxel—melanoma	0.000339	0.0013	CcSEcCtD
Levetiracetam—Chest pain—Docetaxel—melanoma	0.000339	0.0013	CcSEcCtD
Levetiracetam—Arthralgia—Docetaxel—melanoma	0.000339	0.0013	CcSEcCtD
Levetiracetam—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000336	0.00129	CcSEcCtD
Levetiracetam—Dizziness—Carmustine—melanoma	0.000334	0.00128	CcSEcCtD
Levetiracetam—Diarrhoea—Temozolomide—melanoma	0.000334	0.00128	CcSEcCtD
Levetiracetam—Confusional state—Docetaxel—melanoma	0.000327	0.00125	CcSEcCtD
Levetiracetam—Dizziness—Temozolomide—melanoma	0.000323	0.00124	CcSEcCtD
Levetiracetam—Infection—Docetaxel—melanoma	0.000323	0.00123	CcSEcCtD
Levetiracetam—Vomiting—Carmustine—melanoma	0.000321	0.00123	CcSEcCtD
Levetiracetam—Nausea—Dactinomycin—melanoma	0.000321	0.00123	CcSEcCtD
Levetiracetam—Rash—Carmustine—melanoma	0.000319	0.00122	CcSEcCtD
Levetiracetam—Nervous system disorder—Docetaxel—melanoma	0.000318	0.00122	CcSEcCtD
Levetiracetam—Dermatitis—Carmustine—melanoma	0.000318	0.00122	CcSEcCtD
Levetiracetam—Thrombocytopenia—Docetaxel—melanoma	0.000318	0.00122	CcSEcCtD
Levetiracetam—Headache—Carmustine—melanoma	0.000317	0.00121	CcSEcCtD
Levetiracetam—Skin disorder—Docetaxel—melanoma	0.000315	0.00121	CcSEcCtD
Levetiracetam—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000315	0.00684	CbGpPWpGaD
Levetiracetam—Vomiting—Temozolomide—melanoma	0.00031	0.00119	CcSEcCtD
Levetiracetam—Anorexia—Docetaxel—melanoma	0.00031	0.00118	CcSEcCtD
Levetiracetam—Rash—Temozolomide—melanoma	0.000308	0.00118	CcSEcCtD
Levetiracetam—Dermatitis—Temozolomide—melanoma	0.000308	0.00118	CcSEcCtD
Levetiracetam—Headache—Temozolomide—melanoma	0.000306	0.00117	CcSEcCtD
Levetiracetam—Nausea—Carmustine—melanoma	0.0003	0.00115	CcSEcCtD
Levetiracetam—Musculoskeletal discomfort—Docetaxel—melanoma	0.000296	0.00113	CcSEcCtD
Levetiracetam—Insomnia—Docetaxel—melanoma	0.000294	0.00112	CcSEcCtD
Levetiracetam—Paraesthesia—Docetaxel—melanoma	0.000292	0.00112	CcSEcCtD
Levetiracetam—Nausea—Temozolomide—melanoma	0.00029	0.00111	CcSEcCtD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NDRG1—melanoma	0.000289	0.00629	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—MCL1—melanoma	0.000289	0.00629	CbGpPWpGaD
Levetiracetam—Somnolence—Docetaxel—melanoma	0.000289	0.0011	CcSEcCtD
Levetiracetam—CACNA1B—Neuronal System—PRKCA—melanoma	0.000288	0.00626	CbGpPWpGaD
Levetiracetam—Dyspepsia—Docetaxel—melanoma	0.000286	0.00109	CcSEcCtD
Levetiracetam—Decreased appetite—Docetaxel—melanoma	0.000282	0.00108	CcSEcCtD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB5—melanoma	0.000282	0.00613	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HDAC6—melanoma	0.000282	0.00612	CbGpPWpGaD
Levetiracetam—Gastrointestinal disorder—Docetaxel—melanoma	0.00028	0.00107	CcSEcCtD
Levetiracetam—Fatigue—Docetaxel—melanoma	0.00028	0.00107	CcSEcCtD
Levetiracetam—Pain—Docetaxel—melanoma	0.000278	0.00106	CcSEcCtD
Levetiracetam—Constipation—Docetaxel—melanoma	0.000278	0.00106	CcSEcCtD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—BRAF—melanoma	0.000277	0.00602	CbGpPWpGaD
Levetiracetam—Feeling abnormal—Docetaxel—melanoma	0.000268	0.00102	CcSEcCtD
Levetiracetam—SV2A—Disease—NPPA—melanoma	0.000267	0.0058	CbGpPWpGaD
Levetiracetam—Gastrointestinal pain—Docetaxel—melanoma	0.000266	0.00102	CcSEcCtD
Levetiracetam—SV2A—Disease—VCAN—melanoma	0.00026	0.00566	CbGpPWpGaD
Levetiracetam—SV2A—Disease—WNT5A—melanoma	0.000258	0.00562	CbGpPWpGaD
Levetiracetam—Abdominal pain—Docetaxel—melanoma	0.000257	0.000982	CcSEcCtD
Levetiracetam—Body temperature increased—Docetaxel—melanoma	0.000257	0.000982	CcSEcCtD
Levetiracetam—Hypersensitivity—Docetaxel—melanoma	0.000239	0.000915	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—melanoma	0.000237	0.00514	CbGpPWpGaD
Levetiracetam—Asthenia—Docetaxel—melanoma	0.000233	0.000891	CcSEcCtD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—MDM2—melanoma	0.000232	0.00504	CbGpPWpGaD
Levetiracetam—Pruritus—Docetaxel—melanoma	0.00023	0.000879	CcSEcCtD
Levetiracetam—Diarrhoea—Docetaxel—melanoma	0.000222	0.00085	CcSEcCtD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—melanoma	0.000218	0.00475	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—GAB2—melanoma	0.000216	0.0047	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—melanoma	0.000215	0.00468	CbGpPWpGaD
Levetiracetam—Dizziness—Docetaxel—melanoma	0.000215	0.000821	CcSEcCtD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—melanoma	0.000212	0.00462	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—BRAF—melanoma	0.000212	0.00461	CbGpPWpGaD
Levetiracetam—SV2A—Disease—GAB2—melanoma	0.000208	0.00451	CbGpPWpGaD
Levetiracetam—Vomiting—Docetaxel—melanoma	0.000206	0.00079	CcSEcCtD
Levetiracetam—Rash—Docetaxel—melanoma	0.000205	0.000783	CcSEcCtD
Levetiracetam—Dermatitis—Docetaxel—melanoma	0.000205	0.000782	CcSEcCtD
Levetiracetam—Headache—Docetaxel—melanoma	0.000203	0.000778	CcSEcCtD
Levetiracetam—SV2A—Disease—FASN—melanoma	0.000203	0.00442	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—FOXP3—melanoma	0.000197	0.00427	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ARL2—melanoma	0.000196	0.00425	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—ETS1—melanoma	0.000195	0.00425	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CXCR4—melanoma	0.000195	0.00424	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HDAC2—melanoma	0.000195	0.00424	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FOXO4—melanoma	0.000195	0.00424	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD44—melanoma	0.000193	0.0042	CbGpPWpGaD
Levetiracetam—Nausea—Docetaxel—melanoma	0.000193	0.000738	CcSEcCtD
Levetiracetam—ABCC2—NRF2 pathway—SLC5A5—melanoma	0.000185	0.00402	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT3—melanoma	0.000178	0.00387	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—MDM2—melanoma	0.000178	0.00386	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EPO—melanoma	0.000172	0.00374	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—CXCR4—melanoma	0.00016	0.00349	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—MAPK1—melanoma	0.000159	0.00345	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERBB4—melanoma	0.000157	0.00342	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN2B—melanoma	0.000156	0.00339	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CAPN1—melanoma	0.000153	0.00333	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD86—melanoma	0.000151	0.00328	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC15A2—melanoma	0.000148	0.00322	CbGpPWpGaD
Levetiracetam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.000148	0.00322	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—melanoma	0.000148	0.00321	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF1—melanoma	0.000146	0.00318	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC17A5—melanoma	0.000143	0.0031	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PDGFRA—melanoma	0.000142	0.00308	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PRKCA—melanoma	0.00014	0.00305	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERCC2—melanoma	0.000139	0.00302	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAP2K2—melanoma	0.000137	0.00298	CbGpPWpGaD
Levetiracetam—ABCC2—NRF2 pathway—HGF—melanoma	0.000137	0.00298	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CTLA4—melanoma	0.000135	0.00294	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ABCB5—melanoma	0.000133	0.00288	CbGpPWpGaD
Levetiracetam—SV2A—Disease—TERT—melanoma	0.00013	0.00283	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HLA-A—melanoma	0.00013	0.00283	CbGpPWpGaD
Levetiracetam—SV2A—Disease—RAC1—melanoma	0.00013	0.00283	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC6A11—melanoma	0.00013	0.00282	CbGpPWpGaD
Levetiracetam—CACNA1B—Transmission across Chemical Synapses—HRAS—melanoma	0.000127	0.00277	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HIF1A—melanoma	0.000125	0.00271	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—melanoma	0.000124	0.00269	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—EDN1—melanoma	0.000123	0.00267	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—MAPK1—melanoma	0.000121	0.00264	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—melanoma	0.000114	0.00249	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOS2—melanoma	0.000113	0.00247	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NOTCH1—melanoma	0.000112	0.00244	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—melanoma	0.00011	0.0024	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP3K5—melanoma	0.00011	0.0024	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD80—melanoma	0.00011	0.00239	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KIT—melanoma	0.00011	0.00239	CbGpPWpGaD
Levetiracetam—SV2A—Disease—APC—melanoma	0.00011	0.00239	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGF—melanoma	0.000109	0.00236	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD86—melanoma	0.000107	0.00233	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—TERT—melanoma	0.000107	0.00233	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL10—melanoma	0.000105	0.00229	CbGpPWpGaD
Levetiracetam—SV2A—Disease—BRAF—melanoma	0.000103	0.00224	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—HIF1A—melanoma	0.000102	0.00223	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL4—melanoma	0.000102	0.00223	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—DCC—melanoma	0.000102	0.00221	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—PDGFRA—melanoma	0.000101	0.00219	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-B—melanoma	0.0001	0.00218	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APAF1—melanoma	9.88e-05	0.00215	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—FASLG—melanoma	9.78e-05	0.00213	CbGpPWpGaD
Levetiracetam—CACNA1B—Neuronal System—HRAS—melanoma	9.75e-05	0.00212	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAP2K1—melanoma	9.72e-05	0.00211	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CD—melanoma	9.65e-05	0.0021	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—FAS—melanoma	9.43e-05	0.00205	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—melanoma	9.37e-05	0.00204	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—NOS2—melanoma	9.31e-05	0.00203	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-A—melanoma	9.27e-05	0.00202	CbGpPWpGaD
Levetiracetam—SV2A—Disease—FGF2—melanoma	9.24e-05	0.00201	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ARL2—melanoma	9.19e-05	0.002	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MDM2—melanoma	8.65e-05	0.00188	CbGpPWpGaD
Levetiracetam—SV2A—Disease—ERBB2—melanoma	8.53e-05	0.00185	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—HLA-DRB1—melanoma	8.47e-05	0.00184	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CB—melanoma	8.41e-05	0.00183	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CD4—melanoma	8.4e-05	0.00183	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTGS2—melanoma	8.34e-05	0.00181	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—melanoma	8.23e-05	0.00179	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN1B—melanoma	7.9e-05	0.00172	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CD80—melanoma	7.83e-05	0.0017	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CTNNB1—melanoma	7.46e-05	0.00162	CbGpPWpGaD
Levetiracetam—SV2A—Disease—CDKN1A—melanoma	7.29e-05	0.00158	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP8—melanoma	7.28e-05	0.00158	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PTEN—melanoma	7.27e-05	0.00158	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC15A2—melanoma	6.97e-05	0.00151	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC17A5—melanoma	6.71e-05	0.00146	CbGpPWpGaD
Levetiracetam—SV2A—Disease—STAT3—melanoma	6.5e-05	0.00141	CbGpPWpGaD
Levetiracetam—SV2A—Disease—NRAS—melanoma	6.49e-05	0.00141	CbGpPWpGaD
Levetiracetam—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—melanoma	6.3e-05	0.00137	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAPK3—melanoma	6.21e-05	0.00135	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IFNG—melanoma	6.19e-05	0.00135	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC6A11—melanoma	6.09e-05	0.00132	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MYC—melanoma	6.04e-05	0.00131	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—SLC5A5—melanoma	5.92e-05	0.00129	CbGpPWpGaD
Levetiracetam—SV2A—Disease—MAPK1—melanoma	5.91e-05	0.00129	CbGpPWpGaD
Levetiracetam—SV2A—Disease—EGFR—melanoma	5.91e-05	0.00128	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CXCL8—melanoma	5.75e-05	0.00125	CbGpPWpGaD
Levetiracetam—SV2A—Disease—KRAS—melanoma	5.58e-05	0.00121	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—CASP3—melanoma	5.51e-05	0.0012	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—IL2—melanoma	5.5e-05	0.0012	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—melanoma	5.47e-05	0.00119	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—melanoma	5.39e-05	0.00117	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—melanoma	5.13e-05	0.00112	CbGpPWpGaD
Levetiracetam—SV2A—Disease—PIK3CA—melanoma	5.13e-05	0.00112	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—melanoma	5.02e-05	0.00109	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—melanoma	4.97e-05	0.00108	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PRKCA—melanoma	4.92e-05	0.00107	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—melanoma	4.83e-05	0.00105	CbGpPWpGaD
Levetiracetam—SV2A—Disease—HRAS—melanoma	4.75e-05	0.00103	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—melanoma	4.74e-05	0.00103	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ACER3—melanoma	4.71e-05	0.00102	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—VEGFA—melanoma	4.67e-05	0.00102	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—melanoma	4.65e-05	0.00101	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—melanoma	4.56e-05	0.000992	CbGpPWpGaD
Levetiracetam—SV2A—Disease—IL6—melanoma	4.54e-05	0.000988	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ABCB1—melanoma	4.52e-05	0.000982	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—melanoma	4.33e-05	0.000942	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—UGT2B10—melanoma	4.31e-05	0.000936	CbGpPWpGaD
Levetiracetam—SV2A—Disease—AKT1—melanoma	4.19e-05	0.000911	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—melanoma	4.11e-05	0.000894	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—melanoma	4.1e-05	0.00089	CbGpPWpGaD
Levetiracetam—ABCB1—Allograft Rejection—TNF—melanoma	4e-05	0.000871	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HS3ST5—melanoma	4e-05	0.00087	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	3.86e-05	0.000838	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	3.81e-05	0.000829	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	3.59e-05	0.000781	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	3.53e-05	0.000767	CbGpPWpGaD
Levetiracetam—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	3.44e-05	0.000748	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	3.41e-05	0.000742	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	3.24e-05	0.000706	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	3.08e-05	0.00067	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	3.04e-05	0.00066	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLCB4—melanoma	3.03e-05	0.00066	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	2.99e-05	0.000651	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	2.93e-05	0.000636	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIP4K2A—melanoma	2.85e-05	0.00062	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC6A11—melanoma	2.85e-05	0.00062	CbGpPWpGaD
Levetiracetam—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	2.83e-05	0.000614	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.78e-05	0.000605	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—MTAP—melanoma	2.77e-05	0.000603	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	2.77e-05	0.000603	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	2.72e-05	0.000591	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	2.64e-05	0.000575	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	2.62e-05	0.000569	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	2.56e-05	0.000556	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	2.55e-05	0.000555	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	2.54e-05	0.000552	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—LUM—melanoma	2.47e-05	0.000538	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PHGDH—melanoma	2.47e-05	0.000538	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—HPSE—melanoma	2.43e-05	0.000527	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CUBN—melanoma	2.38e-05	0.000518	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	2.31e-05	0.000501	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—BSG—melanoma	2.3e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SDHD—melanoma	2.3e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CSPG4—melanoma	2.3e-05	0.0005	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GPAM—melanoma	2.23e-05	0.000484	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	2.18e-05	0.000474	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	2.12e-05	0.000461	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	2.08e-05	0.000451	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	2.07e-05	0.000451	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	1.98e-05	0.00043	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	1.96e-05	0.000426	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PLA2G6—melanoma	1.89e-05	0.000412	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	1.8e-05	0.000392	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	1.74e-05	0.000379	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—VCAN—melanoma	1.7e-05	0.00037	CbGpPWpGaD
Levetiracetam—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	1.47e-05	0.00032	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP17A1—melanoma	1.43e-05	0.000312	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GNA11—melanoma	1.36e-05	0.000295	CbGpPWpGaD
Levetiracetam—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	1.33e-05	0.000289	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—FASN—melanoma	1.33e-05	0.000288	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—SLC5A5—melanoma	1.3e-05	0.000284	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—GNAQ—melanoma	1.26e-05	0.000274	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CD44—melanoma	1.26e-05	0.000274	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—CYP1B1—melanoma	1.21e-05	0.000263	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PRKCA—melanoma	9.15e-06	0.000199	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ERCC2—melanoma	9.08e-06	0.000197	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CG—melanoma	7.17e-06	0.000156	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PPARG—melanoma	6.92e-06	0.00015	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CD—melanoma	6.3e-06	0.000137	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—ALB—melanoma	6.22e-06	0.000135	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CB—melanoma	5.49e-06	0.000119	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTGS2—melanoma	5.44e-06	0.000118	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PTEN—melanoma	4.75e-06	0.000103	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—PIK3CA—melanoma	3.35e-06	7.28e-05	CbGpPWpGaD
Levetiracetam—ABCB1—Metabolism—AKT1—melanoma	2.74e-06	5.95e-05	CbGpPWpGaD
